DavidMarkLoebMD

Pediatric Hematology & Oncology • Bronx, NY

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor of Pediatrics; Chief, Pediatric Hematology, Oncology, and Marrow & Blood Cell Transplantation, Children's Hospital at Montefiore

Join to view full profile

Dr. Loeb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Loeb's full profile

Already have an account?

Office
3415 Bainbridge Ave
Bronx, NY 10467
Phone+1 718-741-2426

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Johns Hopkins UniversityResidency, Pediatrics, 1994 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994

Certifications & Licensure

NY State Medical License 2017 - 2025
MD State Medical License 1997 - 2018
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Join now to see all

Clinical Trials

Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma Start of enrollment: 2004 Oct 01
Completed
Phase 2
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy Start of enrollment: 2005 Aug 15
Completed
Phase 2
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Start of enrollment: 2009 Sep 01
Completed
Phase 1, Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Stereotactic Radiation Therapy for Pediatric Sarcomas Start of enrollment: 2013 Nov 01
Completed
Not Applicable
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma Start of enrollment: 2013 Aug 19
Terminated
Phase 2
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies Start of enrollment: 2015 Jul 02
Completed
Phase 2
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Sclerosing Epithelioid Fibrosarcoma Harboring the EWSR1 - CREB3L1 Gene Fusion: The Importance of Molecular Classification in Pediatric Sarcomas.
Rachel Offenbacher, Sara Kaswan, Lara Fabish, Carly Barron, Jana Fox
Journal of Pediatric Hematology/oncology. 2024-11-01
Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?
Meghan Davitt, Rachel Offenbacher, Michelle A Lee, David M Loeb, Deepa Manwani
Pediatric Blood & Cancer. 2024-09-01
Human Adenovirus B3 Associated Colitis and Hemophagocytic Lymphohistiocytosis in 9-Year-old Previously Healthy Girl.
Salih Demirhan, Zoe King, Syeda Samar Sohail, Deena Merzel, Daryl M Lamson
The Pediatric Infectious Disease Journal. 2024-07-01

Abstracts/Posters

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...
David Loeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Reduced Intensity Haploidentical BMT for High Risk Solid TumorsMarch 5th, 2013

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-loeb